Skip to main content
PLOS ONE logoLink to PLOS ONE
. 2014 Jan 13;9(1):10.1371/annotation/df796504-a2ea-4807-a412-85985bb2550b. doi: 10.1371/annotation/df796504-a2ea-4807-a412-85985bb2550b

Correction: Glucuronidation by UGT1A1 Is the Dominant Pathway of the Metabolic Disposition of Belinostat in Liver Cancer Patients

Ling-Zhi Wang, Jacqueline Ramírez, Winnie Yeo, Mei-Yi Michelle Chan, Win-Lwin Thuya, Jie-Ying Amelia Lau, Seow-Ching Wan, Andrea Li-Ann Wong, Ying-Kiat Zee, Robert Lim, Soo-Chin Lee, Paul C Ho, How-Sung Lee, Anthony Chan, Sherry Ansher, Mark J Ratain, Boon-Cher Goh
PMCID: PMC3890364

There was an omission in the funding information. The correct funding information is as follows:

"The study was sponsored by the National Research Foundation of Singapore (Experimental Therapeutics Program), the Pharmacogenomics of Anticancer Agents Research (PAAR) Group, NIH/NIGMS U01GM61393 and the National Medical Research Council of Singapore (NMRC/CSA/021/2010). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript."

Footnotes

Competing Interests: No competing interests declared.


Articles from PLoS ONE are provided here courtesy of PLOS

RESOURCES